Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 2 October 2026.

Announcements

2,182

Total raised

£9.5B

disclosed amounts

Seed
£10.4M

The investment was backed by ROKStar Ventures and a group of existing investors to expand the company footprint.

"Operations managers in factories and warehouses have largely been flying blind when it comes to their manual fleets. Slamcore Aware and Slamcore Alert change that from day one, without disruption to existing operations. ROKStar Ventures’ investment tells us that the industry’s most sophisticated players see this as a foundational infrastructure, not just another point solution. As our footprint grows, so does a body of real-world operational data that does not exist anywhere else and that will become the backbone for the next generation of physical AI."
— Owen Nicholson, CEO
Seed
£1.8M

The seed round was backed by Y Combinator and will support US market expansion and product development.

"Crimson is built specifically for litigators, giving them a faster and more reliable way to understand the case file, assess the evidence, and produce high-quality work grounded in the full matter context."
— Mark Feldner, Co-founder and CEO
Seed
$12.0M

The London-based company raised capital from Accel, Air Street Capital, and Elder Gull to grow its engineering team and scale deployments.

"Too many critical drug development decisions still happen without a complete view of the evidence. Perceptic connects data, context, and decision-making so every insight compounds instead of dying at the next handoff."
— Tilman Flock, Co-founder
Seed
£2.1M

THENA Capital led the seed round to help advance Zonova toward major OEM partnerships and international deployment.

"This funding marks a defining moment for Zonova. We founded the company with the belief that infection prevention in medical devices needed a fundamentally new approach, one that moves beyond coatings, antibiotics, and short term fixes. Our technology has the potential to redefine how medical devices are designed globally by embedding antimicrobial protection directly into the material itself. THENA Capital immediately understood both the scale of the clinical problem and the magnitude of the commercial opportunity. The THENA team brings an exceptional combination of scientific depth, strategic insight, and operational ambition that is incredibly rare in venture. We are thrilled to have them leading this round and joining us as we scale toward major OEM partnerships and international deployment."
— Georgia Fleet, CEO and Co-Founder
Seed
£5.0M

The funding round was led by PXN Ventures with participation from IQ Capital and Northern Gritstone.

"What I see right now is that the companies that will make a radical difference in this emerging AI-driven future are all AI-native, lean on real world data, have genuine impact, and are fundamentally deep tech. Imperagen has each of those characteristics, combining them with outstanding people, phenomenal technology and the undeniable swagger you only get from Manchester. It was a no-brainer to join the team and lead this next stage in its growth."
— Guy Levy-Yurista, CEO